ACETO CORPORATION (NASDAQ:ACET) Files An 8-K Financial Statements and Exhibits
Item 9.01(b) of Form 8-K, and does not amend or otherwise update
any other information in the Original Form 8-K. Accordingly, this
Amendment should be read in conjunction with the Original Form
8-K.
| Item 9.01 | Financial Statements and Exhibits. |
(b) Pro Forma Financial Information
The unaudited pro forma financial information is included as
Exhibit 99.1 to this Amendment and is incorporated herein by
reference.
(d) Exhibits:
| ExhibitNo. | Document | |
| 99.1 | Pro Forma Information |
About ACETO CORPORATION (NASDAQ:ACET)
Aceto Corporation (Aceto) is engaged in the marketing, sales and distribution of finished dosage form generic pharmaceuticals, nutraceutical products, pharmaceutical active ingredients and intermediates, specialty performance chemicals inclusive of agricultural intermediates and agricultural protection products. The Company’s business is organized along product lines into three segments: Human Health, Pharmaceutical Ingredients and Performance Chemicals. As of June 30, 2016, it distributed over 1,100 chemical compounds used primarily as finished products or raw materials in the agricultural, coatings and industrial chemical industries. The Human Health segment includes finished dosage form generic drugs and nutraceutical products. As of June 30, 2016, the Pharmaceutical Ingredients segment had two product groups: Active Pharmaceutical Ingredients and Pharmaceutical Intermediates. The Performance Chemicals segment includes specialty chemicals and agricultural protection products. ACETO CORPORATION (NASDAQ:ACET) Recent Trading Information
ACETO CORPORATION (NASDAQ:ACET) closed its last trading session up +0.09 at 15.70 with 263,489 shares trading hands.
